Preferred Name | slaframine | |
Synonyms |
slaframine citrate salt (1:2) (1S-(1 alpha,6 alpha,8a beta))-6-aminooctahydro-1-indolizinol, acetate (ester) (1S,6S,8aS)-1-acetoxy-6-aminooctahydroindolizine |
|
ID |
http://purl.bioontology.org/ontology/MESH/C009275 |
|
altLabel |
slaframine citrate salt (1:2) (1S-(1 alpha,6 alpha,8a beta))-6-aminooctahydro-1-indolizinol, acetate (ester) (1S,6S,8aS)-1-acetoxy-6-aminooctahydroindolizine |
|
cui |
C1563460 C0074664 |
|
HM |
D000470 |
|
II |
D009183 |
|
Inverse of RB |
51H2386GWI 25454-69-7 |
|
Mapped to | ||
MDA |
19740101 |
|
MeSH Frequency |
25 |
|
MMR |
20150927 |
|
notation |
C009275 |
|
PI |
*INDOLIZINES (74-81) |
|
prefLabel |
slaframine |
|
RR |
20084-93-9 (slaframine) 25454-69-7 |
|
SC |
1 |
|
Scope Statement |
biosynthesized in fungus, Rhizoctonia leguminicola; causes excessive salivation in animals; RN given is for parent cpd |
|
SRC |
Biochemistry 12(21):4264;1973 Mol Pharmacol 13(2):185;1977 Biochemistry 18(17):3658;1979 |
|
TERMUI |
T340670 T083850 T083849 |
|
TH |
INN (19XX) FDA SRS (2015) NLM (1974) |
|
tui |
T109 T121 |